Friday, September 29, 2017 9:00:57 AM
Listen, they’re not generating material revenue here to survive, so they have to go after toxic debt. They have to do what they believe is necessary in that case.
In the case of investors, one would hope that the dilution doesn’t hinder the price too much. Well it certainly has, and if it weren’t for the countless paid promos they signed up for, this would be under a penny right now.
The price fell from the .30 range to around .05 in the matter of a few weeks with only good news coming out because they dumped millions of shares in the market in a very short time frame. Not very investor friendly. They did what they thought was necessary, and IMO the investors then did what they thought was necessary and many stopped buying, hence the days where volume was literally non-existant. They try to help prop the volume up anytime they need to dilute more by two ways: paid promos (hit and miss) and “news” which many times lowers the price substantially because they dump way too much with only a slight increase in volume.
This is what it’s always been, a company scraping away with the hopes that one day their vaccine makes it through phase 2 and into phase 3, then hopefully approval. It’s a long shot with all of these companies since it’s so damn difficult to get approved. They have tried to differentiate their product line to create revenue but it’s been a slow process that I’m still waiting to see how impactful those actions will be to the bottom line.
Don’t know what else to say tbh, if you’re in this for the long run then just don’t look at the price at all and hope that one day this hits it big. Just don’t invest more than you can afford to lose.
Recent THER News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:29:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 08:35:09 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/15/2024 10:28:54 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 08:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:10:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:28:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:17:03 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 12/29/2023 04:26:15 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:51:04 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM